TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: Our group detected p53 expression in samples from CML patients analysed by flow cytometry using anti-p53 monoclonal antibodies and an increased expression could be observed as the disease progressed to the blast phase (Table 1).